This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
ALD-52
From PsychonautWiki Archive
Revision as of 11:52, 29 December 2017 by >David Hedlund(Isomer Design)
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.
DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.
1-Acetyl-N,N-diethyllysergamide (also known as ALD-52, 1-Acetyl-LSD, 1A-LSD, 1A-LAD, and mistakenly as Orange Sunshine) is a novel synthetic psychedelic of the lysergamide chemical class that produces "classical psychedelic" effects reported to be virtually indistinguishable from those of LSD when administered. It is a closely related structural analog and a suspected prodrug of LSD, meaning it is inactive until it enters the body and is converted into LSD.[citation needed]
ALD-52 was originally discovered by Albert Hofmann in his study of LSD analogs[citation needed], but it did not enter mainstream awareness until psychedelics came to occupy a central role in the 1960s Western youth counterculture. ALD-52 gained public notoriety when it supposedly distributed in the 1960s as LSD under the now-famous name "Orange Sunshine." This was later disproven (see section below).
Alexander Shulgin touches briefly on the subject of ALD-52 in the commentary section of LSD-25 in the book TiHKAL ("Tryptamines I have Known and Loved").[1] His writings are based on second-hand accounts which state that doses in the 50-175 µg range result in various effects that are not particularly distinct from LSD. His reports indicate that it produces less visual distortion than with LSD as well as less anxiety and tenseness, while also being somewhat less potent than LSD. Another report found the two substances to be indistinguishable.[1]
These reports are generally consistent with anecdotal reports of its effects that have followed since it was made accessible for the first time as a research chemical.
Today, ALD-52 is available on the research chemicals online gray market as part of a series of designer druglysergamides which include compounds like AL-LAD, ETH-LAD, 1P-LSD and PRO-LAD. While it only has a short history of human use, reports almost unanimously agree that it is nearly identical if not slightly preferable to LSD due to its relatively mellow nature at common doses and the low likelihood of it possessing any unexpected toxicity due to its likely prodrug status. Nevertheless, it is still strongly advised to approach this potent psychedelic with the proper amount of precaution and harm reduction techniques if choosing to use it.
As a result, it may contain incomplete or wrong information. You can help by expanding it.
In 2017, it came to light that the infamous "Orange Sunshine" variety of LSD that was widely available in California through 1968 and 1969 was not ALD-52 as it was long held by the hippie generation and that "Orange Sunshine" was just a very well made batch of 250 microgram per unit batch of LSD. The notorious psychedelic chemist it was attributed to, Nick Sands, confirmed that the claim of synthesizing the unscheduled drug ALD-52 and selling it as LSD was completely fabricated for his and Tim Scully's court case to argue that they were not guilty of selling LSD.[2]
Chemistry
ALD-52, or 1-Acetyl-N,N-diethyllysergamide, is a semisynthethic molecule of the lysergamide chemical class. ALD-52 is a substituted derivative of lysergic acid. ALD-52's structure contains four rings, a bicyclic hexahydroindole fused to a bicyclic quinoline group. This core structure of ALD-52 is an ergoline derivative, and has tryptamine and phenethylamine structures embedded within it. ALD-52 contains a N,N-diethylcarboxamide functional group bound to R8 of the chemical structure. It is additionally substituted at carbon 6 with a methyl group.
ALD-52 is homologous to 1P-LSD, which contains a propionyl group bound to CH3CO- instead of the acetyl group bound to the same location. It is unknown how these differences account for differences in the two compound's activity.
ALD-52 likely acts as a 5-HT2Apartial agonist. The psychedelic effects are believed to come from ALD-52's efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
ALD-52, alongside with 1P-LSD, is believed to act as a prodrug to LSD, though it is unclear as to whether it is capable of exerting its own effects.[citation needed]
Subjective effects
Anecdotal reports from many users suggest that the effects of ALD-52 are essentially the same to that of its close structural relative LSD with whatever differences being so small so as to be considered virtually indistinguishable from one another. In comparison to other psychedelics such as psilocin, LSA and ayahuasca, ALD-52 is significantly more stimulating and fast-paced regarding the specific style of its physical and cognitive effects, in line with other lysergamides.
While it is unclear to what extent these have any pharmacological basis, anecdotal reports from the community tend to report ALD-52 as being slightly less potent and visual, with a mellower, less anxiety-provoking headspace that comes at the expense of less depth, giving it the reputation for being a more recreational variant of LSD. It has been speculated that this is due to a slightly extended, less jarring come up period that allows the user to become more acclimated to the changes in head space. As one increases the dose however, it is reported to lose this character and subjectively converge with the effects of a high-dose LSD experience.
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWikicontributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
Physical effects
Spontaneous physical sensations - The "body high" of ALD-52 can be characterized as proportionally very intense in comparison to its accompanying visual and cognitive effects. It behaves as a euphoric, fast-moving, sharp and location specific tingling sensation. For some, it is manifested spontaneously at different, unpredictable points throughout the trip, but for most, it maintains a steady presence that rises with the onset and hits its limit once the peak has been reached. At moderate to high doses of ALD-52, this sensation often approaches its highest level and can become so overwhelming that people may find themselves writhing on the floor in pleasure.
Physical euphoria - It should be noted that this effect is not as reliably induceable as it is with substances like stimulants or entactogens, and can just as easily manifest as physical discomfort without any apparent reason.
Tactile enhancement - Feelings of enhanced tactile sensations are consistently present at moderate levels throughout most ALD-52 trips. If level 8A geometry is reached, an intense sensation of suddenly becoming aware of and being able to feel every single nerve ending across a person's entire body all at once is consistently present.
Changes in felt bodily form - This effect is often accompanied by a sense of warmth or unity and usually occurs during and up to the peak of the experience or directly afterwards. Users can feel as if they are physically part of or conjoined with other objects. This is usually reported as feeling comfortable in its sensations and even peaceful.
Stimulation & Sedation - In terms of its effects on the physical energy levels of the user, ALD-52 is regarded as being able to produce a spectrum of either predominantly stimulating or sedating effects, often alternating throughout the experience, often to the point of feeling forced. This is in distinction to other, more commonly used psychedelics such as psilocybin which are more consistent in producing sedation and relaxedness.
Nausea - Mild nausea is occasionally reported when consumed in moderate to high dosages and either passes instantly soon after the user has vomited or gradually fades by itself as the peak sets in.
Stamina enhancement - This is generally mild in comparison to the stamina enhancement produced by traditional stimulants.
Seizure - This is a rare effect whose likelihood is largely extrapolated from the seizures that have been reported from the use of LSD due to a lack of research. They are thought to mainly be a risk in those who are genetically predisposed to them, particularly while accompanied by physically taxing conditions such as states of dehydration, undernourishment, overheating, or general fatigue.
Visual effects
Enhancements
Colour enhancement - In comparison to other psychedelics, this effect is often reported to be brighter but not as varied in its character.
Drifting(melting, breathing, morphing and flowing) - In comparison to other psychedelics, this effect can be described as highly detailed and cartoon-like in its appearance. The distortions are slow and smooth in motion and fleeting in appearance.
The visual geometry that is present throughout this trip can be described as more similar in appearance to that of 2C-B or 2C-I than psilocin, LSA or DMT. It can be comprehensively described through its variations as primarily intricate in complexity, algorithmic in form, unstructured in organization, brightly lit, colourful in scheme, synthetic in feel, multicoloured in scheme, flat in shading, sharp in edges, large in size, fast in speed, smooth in motion, angular in its corners, non-immersive in-depth and consistent in intensity.
In the case of higher level geometry, this substance is level 8A dominant but is also capable of inducing 8B Geometry under the right circumstances.
Hallucinatory states
ALD-52 is capable of producing a full range of low and high level hallucinatory states in a fashion that is significantly less consistent and reproducible than that of many other commonly used psychedelics, specifically tryptamines like DMT or psilocybin mushrooms. These effects include:
Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots) - Although ALD-52 is technically capable of producing hallucinatory states in a fashion that is on par with psilocin or DMT in its vividness and intensity, these effects are incredibly rare and inconsistent in comparison. While traditional psychedelics such as LSA, ayahuasca and mescaline will induce internal hallucinations near consistently at level 5 geometry and above, ALD-52 will for most simply go straight into Level 8A visual geometry. This lack of consistently induced hallucinatory breakthroughs means that for most, LSD is simply not as deep of an experience as certain other psychedelics. On the rare occasion that they are induced, however, they can be comprehensively described in terms of their variations as lucid in believability, interactive in style, new experiences in content, autonomous in controllability and geometry-based in appearance.
The cognitive effects of ALD-52 can be broken down into several components which progressively intensify proportional to dosage. In comparison to other psychedelics such as psilocybin, LSA and ayahuasca, ALD-52 is significantly more stimulating and fast-paced in terms of the specific style of thought streams produced and contains a large number of potential effects that is attributed to its binding activity at a wide range of monoamine receptors other than serotonin, specifically dopamine and norepinephrine.
The most prominent of these cognitive effects generally include:
Anxiety & Paranoia - These effects are reported to be not as common at low to moderate doses and is less likely to occur when the basic rules of set and setting are taken into account. It should be noted that this inconsistently induced effect is seemingly more likely to manifest when used with cannabis. ALD-52 is often reported as producing less anxiety, particularly during the come up phase, relative to LSD.
Cognitive euphoria - This component is, generally speaking less consistent and pronounced than it is with substances like psilocybin and MDMA. The mental euphoria experienced on LSD is usually simply due to an enhancement of the user’s current psychological and emotional state coupled with its more regularly occurring effect, physical euphoria.
Laughter - This can manifest prominently during a ALD-52 experience, particularly during the come up phase, often resulting in bouts of uncontrollable giggles and laughter that can form a feedback loop if around others who are also under the influence.
Synaesthesia - In its fullest manifestation, this is a very rare and non-reproducible effect. Increasing the dosage can increase the likelihood of this occurring, but seems to only be a prominent part of the experience among those who are already predisposed to synaesthetic states.
Cannabis - When used in conjunction with cannabis, both the visual and cognitive effects of ALD-52 can be intensified and extended with extreme efficiency. This should be used with extreme caution, especially if one is not experienced with psychedelics. Many users sometimes report a dramatically more intense visual trip when combining it with THC concentrates such as hashish as opposed to cannabis flower; however, this can also amplify the anxiety, paranoia, confusion and psychosis producing aspects of cannabis to a dangerous degree, which can often act as a catalyst for suddenly turning an enjoyable experience into an overwhelming "bad trip".
Dissociatives - When used in combination with dissociatives, the geometry, euphoria, dissociation and hallucinatory effects are often greatly enhanced. Dissociative-induced holes, spaces, and voids while under the influence of ALD-52 can result in significantly more vivid visuals than dissociatives alone present, along with more intense internal hallucinations, confusion, delusions and chances of a psychotic reaction. Additionally, users should be aware that there are reasons to believe that this combination may result in unforeseen neurotoxic effects, so a strong sense of caution and independent research are highly advised if one decides to experiment with this combination.
MDMA - When used in conjunction with MDMA, the physical and cognitive effects of MDMA become amplified. The visual, physical and cognitive effects of ALD-52 are also intensified with an overwhelming euphoric pleasure manifested through uniquely pleasurable body highs and headspaces, and uniquely colorful and awe-inspiring visuals. The synergy between these substances is unpredictable, and it is best to start with markedly lower dosages than one would take for both substances individually. Additionally, users should be aware that there are reasons to believe that this combination may result in unforeseen neurotoxic effects,[citation needed] so a strong sense of caution and independent research are highly advised if one decides to experiment with this combination.
Alcohol - This interaction is not typically recommended due to alcohol’s ability to cause dehydration, depression and thought disorganization which can negatively affect a trip if taken in high dosages. This combination is however reasonably safe in low doses and when used responsibly, this can often take the edge off a trip as well as dull its psychedelic effects in a fashion somewhat similar to benzodiazepines, albeit more stressful on the body.
Benzodiazepines - When used in combination with benzodiazepines, benzodiazepines can, depending on the dosage, slightly to completely reduce the intensity of the cognitive, physical and visual effects of an ALD-52 trip. They are very efficient at stopping "bad trips" at the cost of amnesia and reduced trip intensity. Caution is advised when acquiring them for this purpose, however, due to the very high addiction potential that benzodiazepines possess.
Psychedelics - When used in combination with other psychedelics, each drug's physical, cognitive and visual effects intensify and synergize strongly. The synergy between those substances is unpredictable, and for this reason generally not advised. If choosing to combine psychedelics, it is recommended to start with lower dosages than one would take for either substance individually.
The toxicity and long-term health effects of recreational ALD-52 use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because ALD-52 is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried ALD-52 suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). With respect to toxicity, its close molecular similarity and the likely prodrug relationship to LSD suggests it is highly unlikely to be any more toxic than LSD itself, though this has yet to be scientifically validated. However, it has been postulated that it can act as a potential trigger for those with underlying psychiatric conditions, so those with either a personal or family history of mental illness are generally advised not to use this substance.Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
Tolerance and addiction potential
ALD-52 is not habit-forming and the desire to use it can actually decrease with repeated administration. Like with most psychedelics, it is thought to be most often self-regulating rather than self-reinforcing.
Tolerance to the effects of ALD-52 build almost immediately after ingestion. After that, it takes about 5-7 days for the tolerance to be reduced to half and 14 days to be back at baseline (in the absence of further consumption). ALD-52 presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of ALD-52 all psychedelics will have a reduced effect.
Dangerous interactions
Although many substances are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be relatively harmless in low doses of each but can still increase the risk of unpredictable injury or death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
Tramadol - Tramadol lowers the seizure threshold[3] and psychedelics may act as triggers for seizures, particularly in those who are predisposed to them.[citation needed]
Stimulants - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable anxiety, panic, thought loops and paranoia. This interaction may cause elevated risk of psychosis.[citation needed]
Lithium - Lithium is often used as treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its glutaminergic and GABAergic effects.[citation needed]
As such, it may contain incomplete or wrong information. You can help by expanding it.
United Kingdom: As of January 7th, 2015, ALD-52 is specifically named in the U.K. Misuse of Drugs Act as a Class A drug.[4]
Latvia: ALD-52 is illegal in Latvia. Although it isn't officially scheduled, it is controlled as an LSD structural analog due to an amendment made on June 1, 2015.[5]
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113
Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature Publishing Group, 11(9), 642–651. https://doi.org/10.1038/nrn2884
Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioral Brain Research, 277, 99–120. https://doi.org/10.1016/j.bbr.2014.07.016
Thisted, D. M. R. A., & Nichols, D. E. (2005). Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis, 427–435. https://doi.org/10.1007/s00213-005-2183-9
Nichols, C. D., Garcia, E. E., & Sanders-bush, E. (2003). Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration, 111, 182–188. PMID: 12654518
↑Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089
